Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project.

Fofaria RK, Barber S, Adeleke Y, Woodcock T, Kamperidis N, Mohamed A, Misra R, Shah A, Bailey-Fee S, Bluston H, Robinson D, Tyrrell T, Arebi N.

BMJ Open Qual. 2019 Aug 1;8(3):e000546. doi: 10.1136/bmjoq-2018-000546. eCollection 2019.

2.

Transitions of care across hospital settings in patients with inflammatory bowel disease.

Warren LR, Clarke JM, Arora S, Barahona M, Arebi N, Darzi A.

World J Gastroenterol. 2019 May 7;25(17):2122-2132. doi: 10.3748/wjg.v25.i17.2122.

3.

Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.

Burisch J, Zammit SC, Ellul P, Turcan S, Duricova D, Bortlik M, Andersen KW, Andersen V, Kaimakliotis IP, Fumery M, Gower-Rousseau C, Girardin G, Valpiani D, Goldis A, Brinar M, Čuković-Čavka S, Oksanen P, Collin P, Barros L, Magro F, Misra R, Arebi N, Eriksson C, Halfvarson J, Kievit HAL, Pedersen N, Kjeldsen J, Myers S, Sebastian S, Katsanos KH, Christodoulou DK, Midjord J, Nielsen KR, Kiudelis G, Kupcinskas L, Nikulina I, Belousova E, Schwartz D, Odes S, Salupere R, Carmona A, Pineda JR, Vegh Z, Lakatos PL, Langholz E, Munkholm P; Epi-IBD group.

J Gastroenterol Hepatol. 2019 Jun;34(6):996-1003. doi: 10.1111/jgh.14563. Epub 2019 Jan 21.

PMID:
30562421
4.

UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation.

Yiannakou Y, Agrawal A, Allen PB, Arebi N, Brown SR, Eugenicos MP, Farmer AD, McLain-Smith S, McLaughlin J, Sanders DS, Lawrance D, Emmanuel A.

Therap Adv Gastroenterol. 2018 Oct 3;11:1756284818798791. doi: 10.1177/1756284818798791. eCollection 2018.

5.

Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study.

Burisch J, Katsanos KH, Christodoulou DK, Barros L, Magro F, Pedersen N, Kjeldsen J, Vegh Z, Lakatos PL, Eriksson C, Halfvarson J, Fumery M, Gower-Rousseau C, Brinar M, Cukovic-Cavka S, Nikulina I, Belousova E, Myers S, Sebastian S, Kiudelis G, Kupcinskas L, Schwartz D, Odes S, Kaimakliotis IP, Valpiani D, D'Incà R, Salupere R, Chetcuti Zammit S, Ellul P, Duricova D, Bortlik M, Goldis A, Kievit HAL, Toca A, Turcan S, Midjord J, Nielsen KR, Andersen KW, Andersen V, Misra R, Arebi N, Oksanen P, Collin P, de Castro L, Hernandez V, Langholz E, Munkholm P; Epi-IBD Group.

J Crohns Colitis. 2019 Feb 1;13(2):198-208. doi: 10.1093/ecco-jcc/jjy154.

PMID:
30289522
6.

Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.

Chetcuti Zammit S, Ellul P, Girardin G, Valpiani D, Nielsen KR, Olsen J, Goldis A, Lazar D, Shonová O, Nováková M, Sebastian S, Whitehead E, Carmona A, Martinez-Cadilla J, Dahlerup JF, Kievit ALH, Thorsgaard N, Katsanos KH, Christodoulou DK, Magro F, Salupere R, Pedersen N, Kjeldsen J, Carlsen K, Ioannis K, Bergemalm D, Halfvarson J, Duricova D, Bortlik M, Collin P, Oksanen P, Kiudelis G, Kupcinskas L, Kudsk K, Andersen V, O'Morain C, Bailey Y, Doron S, Shmuel O, Almer S, Arebi N, Misra R, Čuković-Čavka S, Brinar M, Munkholm P, Vegh Z, Burisch J.

Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1297-1303. doi: 10.1097/MEG.0000000000001238.

PMID:
30134383
7.

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.

Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2442-2451. doi: 10.1093/ibd/izy155.

PMID:
29788318
8.

Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups.

Misra R, Faiz O, Munkholm P, Burisch J, Arebi N.

World J Gastroenterol. 2018 Jan 21;24(3):424-437. doi: 10.3748/wjg.v24.i3.424.

9.

Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.

Burisch J, Kiudelis G, Kupcinskas L, Kievit HAL, Andersen KW, Andersen V, Salupere R, Pedersen N, Kjeldsen J, D'Incà R, Valpiani D, Schwartz D, Odes S, Olsen J, Nielsen KR, Vegh Z, Lakatos PL, Toca A, Turcan S, Katsanos KH, Christodoulou DK, Fumery M, Gower-Rousseau C, Chetcuti Zammit S, Ellul P, Eriksson C, Halfvarson J, Magro FJ, Duricova D, Bortlik M, Fernandez A, Hernández V, Myers S, Sebastian S, Oksanen P, Collin P, Goldis A, Misra R, Arebi N, Kaimakliotis IP, Nikuina I, Belousova E, Brinar M, Cukovic-Cavka S, Langholz E, Munkholm P; Epi-IBD group.

Gut. 2018 Jan 23. pii: gutjnl-2017-315568. doi: 10.1136/gutjnl-2017-315568. [Epub ahead of print]

PMID:
29363534
10.

The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery.

Kamperidis N, Faiz O, Arebi N.

Ann Surg. 2017 Dec;266(6):e61-e62. doi: 10.1097/SLA.0000000000001502. No abstract available.

PMID:
29136975
11.

Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom Study.

Burisch J, Vegh Z, Katsanos KH, Christodoulou DK, Lazar D, Goldis A, O'Morain C, Fernandez A, Pereira S, Myers S, Sebastian S, Pedersen N, Olse J, Rubek Nielsen K, Schwartz D, Odes S, Almer S, Halfvarson J, Turk N, Cukovic-Cavka S, Nikulina I, Belousova E, Duricova D, Bortlik M, Shonová O, Salupere R, Barros L, Magro F, Jonaitis L, Kupcinskas L, Turcan S, Kaimakliotis I, Ladefoged K, Kudsk K, Andersen V, Vind I, Thorsgaard N, Oksanen P, Collin P, Dal Piaz G, Santini A, Niewiadomski O, Bell S, Moum B, Arebi N, Kjeldsen J, Carlsen K, Langholz E, Lakatos PL, Munkholm P, Gerdes LU, Dahlerup JF; EpiCom study group.

J Crohns Colitis. 2017 Oct 1;11(10):1213-1222. doi: 10.1093/ecco-jcc/jjx077.

PMID:
28575481
12.

Re: Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.

Misra R, Arebi N.

Gastroenterology. 2017 Jun;152(8):2082-2083. doi: 10.1053/j.gastro.2017.02.041. Epub 2017 May 4. No abstract available.

13.

Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.

Mowat C, Arnott I, Cahill A, Smith M, Ahmad T, Subramanian S, Travis S, Morris J, Hamlin J, Dhar A, Nwokolo C, Edwards C, Creed T, Bloom S, Yousif M, Thomas L, Campbell S, Lewis SJ, Sebastian S, Sen S, Lal S, Hawkey C, Murray C, Cummings F, Goh J, Lindsay JO, Arebi N, Potts L, McKinley AJ, Thomson JM, Todd JA, Collie M, Dunlop MG, Mowat A, Gaya DR, Winter J, Naismith GD, Ennis H, Keerie C, Lewis S, Prescott RJ, Kennedy NA, Satsangi J; TOPPIC Study Group.

Lancet Gastroenterol Hepatol. 2016 Dec;1(4):273-282. doi: 10.1016/S2468-1253(16)30078-4. Epub 2016 Aug 30.

14.

Colectomy Rates for Ulcerative Colitis Differ between Ethnic Groups: Results from a 15-Year Nationwide Cohort Study.

Misra R, Askari A, Faiz O, Arebi N.

Can J Gastroenterol Hepatol. 2016;2016:8723949. doi: 10.1155/2016/8723949. Epub 2016 Dec 15.

15.

A review of endoscopic balloon dilatation techniques for treating Crohn's strictures: time to standardise therapy.

Arebi N, Hart AL, Thomas-Gibson S.

Expert Rev Gastroenterol Hepatol. 2016 Oct;10(10):1101-1107. doi: 10.1080/17474124.2016.1212656. Epub 2016 Jul 27.

PMID:
27411078
16.

Endoscopic Dilatation of Crohn's Anastomotic Strictures is Effective in the Long Term, and Escalation of Medical Therapy Improves Outcomes in the Biologic Era.

Ding NS, Yip WM, Choi CH, Saunders B, Thomas-Gibson S, Arebi N, Humphries A, Hart A.

J Crohns Colitis. 2016 Oct;10(10):1172-8. doi: 10.1093/ecco-jcc/jjw072. Epub 2016 Mar 12.

PMID:
26971054
17.

Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn's disease strictures.

Morar PS, Faiz O, Warusavitarne J, Brown S, Cohen R, Hind D, Abercrombie J, Ragunath K, Sanders DS, Arnott I, Wilson G, Bloom S, Arebi N; Crohn's Stricture Study (CroSS) Group.

Aliment Pharmacol Ther. 2015 Nov;42(10):1137-48. doi: 10.1111/apt.13388. Epub 2015 Sep 11. Review.

18.

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.

Burisch J, Weimers P, Pedersen N, Cukovic-Cavka S, Vucelic B, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O'Morain C, Schwartz D, Odes S, Valpiani D, Boni MC, Jonaitis L, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Sanroman L, Almer S, Zhulina Y, Halfvarson J, Arebi N, Diggory T, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom-group.

J Crohns Colitis. 2014 Sep;8(9):1030-42. doi: 10.1016/j.crohns.2014.01.028. Epub 2014 Feb 21.

PMID:
24560877
19.

Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study.

Burisch J, Vegh Z, Pedersen N, Cuković-Čavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Ragnarsson G, Björnsson E, Bailey Y, O'Morain C, Schwartz D, Odes S, Politi P, Santini A, Kiudelis G, Kupcinskas L, Turcan S, Magro F, Barros L, Lazar D, Goldis A, Nikulina I, Belousova E, Sanromán L, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Houston Y, Sebastian S, Langholz E, Lakatos PL, Munkholm P; EpiCom group.

J Crohns Colitis. 2014 Aug;8(8):811-8. doi: 10.1016/j.crohns.2013.12.023. Epub 2014 Jan 16.

PMID:
24439390
20.

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O'Morain C, Schwartz D, Odes S, Giannotta M, Girardin G, Kiudelis G, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Martinez-Ares D, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Arebi N, Tsai HH, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom-group.

J Crohns Colitis. 2014 Jul;8(7):607-16. doi: 10.1016/j.crohns.2013.11.021. Epub 2013 Dec 7.

PMID:
24315795
21.

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.

Burisch J, Pedersen N, Čuković-Čavka S, Brinar M, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Andersen V, Krabbe S, Dahlerup JF, Salupere R, Nielsen KR, Olsen J, Manninen P, Collin P, Tsianos EV, Katsanos KH, Ladefoged K, Lakatos L, Björnsson E, Ragnarsson G, Bailey Y, Odes S, Schwartz D, Martinato M, Lupinacci G, Milla M, De Padova A, D'Incà R, Beltrami M, Kupcinskas L, Kiudelis G, Turcan S, Tighineanu O, Mihu I, Magro F, Barros LF, Goldis A, Lazar D, Belousova E, Nikulina I, Hernandez V, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom-group.

Gut. 2014 Apr;63(4):588-97. doi: 10.1136/gutjnl-2013-304636. Epub 2013 Apr 20.

PMID:
23604131
22.

A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease.

Al-Hassi HO, Bernardo D, Murugananthan AU, Mann ER, English NR, Jones A, Kamm MA, Arebi N, Hart AL, Blakemore AI, Stagg AJ, Knight SC.

Mucosal Immunol. 2013 Jul;6(4):751-61. doi: 10.1038/mi.2012.113. Epub 2012 Nov 21.

23.

Role of biological therapy for inflammatory bowel disease in developing countries.

Arebi N.

Gut. 2013 Feb;62(2):334. doi: 10.1136/gutjnl-2012-303383. Epub 2012 Sep 1. No abstract available.

PMID:
22942240
24.

Endoscopy in inflammatory bowel disease when and why.

Rameshshanker R, Arebi N.

World J Gastrointest Endosc. 2012 Jun 16;4(6):201-11. doi: 10.4253/wjge.v4.i6.201.

25.

Distinct neurophysiological profiles in irritable bowel syndrome.

Arebi N, Bullas DC, Dukes GE, Gurmany S, Hicks KJ, Kamm MA, Hobson AR.

Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1086-93. doi: 10.1152/ajpgi.00553.2010. Epub 2011 Feb 24.

26.

Systematic review of abdominal surgery for chronic idiopathic constipation.

Arebi N, Kalli T, Howson W, Clark S, Norton C.

Colorectal Dis. 2011 Dec;13(12):1335-43. doi: 10.1111/j.1463-1318.2010.02465.x. Review.

PMID:
20969711
27.

Dynamic patient position changes during colonoscope withdrawal increase adenoma detection: a randomized, crossover trial.

East JE, Bassett P, Arebi N, Thomas-Gibson S, Guenther T, Saunders BP.

Gastrointest Endosc. 2011 Mar;73(3):456-63. doi: 10.1016/j.gie.2010.07.046. Epub 2010 Oct 15.

PMID:
20950801
28.

Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland.

Russo EA, Iacucci M, Lindsay JO, Campbell S, Hart A, Hamlin J, Orchard T, Arebi N, Nightingale J, Jacyna MR, Gabe SM, O'Connor M, Harris AW, O'Morain C, Ghosh S.

Eur J Gastroenterol Hepatol. 2010 Mar;22(3):334-9. doi: 10.1097/MEG.0b013e32832b20d4.

PMID:
19528808
29.

Predictive value and clinical significance of myenteric plexitis in Crohn's disease.

Ng SC, Lied GA, Kamm MA, Sandhu F, Guenther T, Arebi N.

Inflamm Bowel Dis. 2009 Oct;15(10):1499-507. doi: 10.1002/ibd.20932.

PMID:
19338051
30.

Clinical and surgical recurrence of Crohn's disease after ileocolonic resection in a specialist unit.

Ng SC, Lied GA, Arebi N, Phillips RK, Kamm MA.

Eur J Gastroenterol Hepatol. 2009 May;21(5):551-7. doi: 10.1097/MEG.0b013e328326a01e.

PMID:
19182680
31.

Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.

Russo EA, Harris AW, Campbell S, Lindsay J, Hart A, Arebi N, Milestone A, Tsai HH, Walters J, Carpani M, Westaby D, Thillainayagam A, Bansi D, Ghosh S.

Aliment Pharmacol Ther. 2009 Feb 1;29(3):308-14. doi: 10.1111/j.1365-2036.2008.03890.x. Epub 2008 Nov 13.

32.

Review article: the psychoneuroimmunology of irritable bowel syndrome--an exploration of interactions between psychological, neurological and immunological observations.

Arebi N, Gurmany S, Bullas D, Hobson A, Stagg A, Kamm M.

Aliment Pharmacol Ther. 2008 Oct 1;28(7):830-40. doi: 10.1111/j.1365-2036.2008.03801.x. Epub 2008 Jul 10. Review.

33.

Endoscopic mucosal resection of 161 cases of large sessile or flat colorectal polyps.

Arebi N, Swain D, Suzuki N, Fraser C, Price A, Saunders BP.

Scand J Gastroenterol. 2007 Jul;42(7):859-66.

PMID:
17558911
34.

Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.

Ng SC, Arebi N, Kamm MA.

Inflamm Bowel Dis. 2007 Feb;13(2):129-34.

PMID:
17206694
35.

Position changes improve visibility during colonoscope withdrawal: a randomized, blinded, crossover trial.

East JE, Suzuki N, Arebi N, Bassett P, Saunders BP.

Gastrointest Endosc. 2007 Feb;65(2):263-9. Epub 2006 Dec 4.

PMID:
17141772
36.

A novel method of treating colonic angiodysplasia.

Suzuki N, Arebi N, Saunders BP.

Gastrointest Endosc. 2006 Sep;64(3):424-7.

PMID:
16923494
37.

A 22-year-old woman with recurrent gastrointestinal bleeding since childhood.

Arebi N, Fraser C.

Libyan J Med. 2006 Sep 18;1(1):96-9. doi: 10.4176/060806. No abstract available.

38.

IgA multiple myeloma presenting as non-obstructive jaundice.

Arebi N, Patel B, Aqel NM, Pitcher MC.

Postgrad Med J. 2004 Aug;80(946):489-90.

39.

High-output fistula.

Arebi N, Forbes A.

Clin Colon Rectal Surg. 2004 May;17(2):89-98. doi: 10.1055/s-2004-828655.

40.

Nitric oxide regulates the release of somatostatin from cultured gastric rabbit primary D-cells.

Arebi N, Healey ZV, Bliss PW, Ghatei M, Van Noorden S, Playford RJ, Calam J.

Gastroenterology. 2002 Aug;123(2):566-76.

PMID:
12145809
41.

Helicobacter pylori infection in the cat: evaluation of gastric colonization, inflammation and function.

Simpson KW, Strauss-Ayali D, Straubinger RK, Scanziani E, McDonough PL, Straubinger AF, Chang YF, Esteves MI, Fox JG, Domeneghini C, Arebi N, Calam J.

Helicobacter. 2001 Mar;6(1):1-14.

PMID:
11328360
42.

Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats.

Simpson KW, Strauss-Ayali D, Scanziani E, Straubinger RK, McDonough PL, Straubinger AF, Chang YF, Domeneghini C, Arebi N, Calam J.

Infect Immun. 2000 Feb;68(2):779-90.

43.

Nalpha-methyl histamine and histamine stimulate gastrin release from rabbit G-cells via histamine H2-receptors.

Bliss PW, Healey ZV, Arebi N, Calam J.

Aliment Pharmacol Ther. 1999 Dec;13(12):1669-74.

44.

Effect of PACAP-27 on 14C-aminopyrine accumulation in isolated rabbit parietal cells.

Healey ZV, Bliss P, Edwards J, Arebi N, Beales IL, Calam J.

Peptides. 1998;19(6):1111-4.

PMID:
9700763
45.

How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology.

Calam J, Gibbons A, Healey ZV, Bliss P, Arebi N.

Gastroenterology. 1997 Dec;113(6 Suppl):S43-9; discussion S50. Review.

PMID:
9394759

Supplemental Content

Support Center